Increased levels of IL-21 have been found in mice with chronic DSS-induced and TNBS-induced colitis, and IL-21 blockade by the addition of neutralizing IL-21R fusion proteins to DSS-treated mice mitigates colitis and inhibits the release of the main Th17 cytokines [186]. Here, IL21 is linked to colitis.